Patent application number | Description | Published |
20090187115 | Temperature measurement device - A device for non-invasive measurement of the internal temperature of a physical body or thermal resistivity, the body comprising a thermally conductive medium between an internal region with a substantially constant internal temperature and an external surface with a surface temperature. The device comprises: a patch comprising one or more contact components for attachment to the external surface and an insulating cover for substantially thermally insulating the contact component from ambient thermal conditions; a reader for acquiring one or more thermal magnitudes on the patch; a processing unit for processing the thermal magnitudes to derive the internal temperature of the internal region or the thermal resistivity of the conductive medium. | 07-23-2009 |
20120083710 | ERGONOMIC HAND-HELD THERMOMETER - A thermometer useful for measuring the temperature of a patient, the thermometer including a housing, at least one temperature sensor assembly including a plurality of external patient skin contacting surfaces, and a mounting element for mounting the at least one temperature sensor assembly on the housing and being operative for mutually independently mounting each of the plurality of external patient skin contacting surfaces to be independently arrangeable in a spatial orientation which may be independently different from the spatial orientation of the external patient skin contacting surface of each other of the plurality of external patient skin contacting surfaces. | 04-05-2012 |
20150211944 | INTERFACE BETWEEN VITAL-SIGNS SENSORS AND PATIENT MONITOR - An apparatus includes at least one sensor, a connector and a conversion unit. The sensor is coupled to a patient body so as to measure a physiological parameter of the body. The connector coupled to a patient monitor, which measures a value of the physiological parameter by applying a test signal via the connector and measuring a response signal on the connector in response to the test signal. The conversion unit is coupled between the at least one sensor and the connector, and is configured to determine a corrected value of the physiological parameter, to calculate an auxiliary signal that, in combination with the test signal produced by the patient monitor, causes the response signal on the connector to represent the corrected value of the physiological parameter, and to generate and output the auxiliary signal to the connector so as to cause the patient monitor to measure the corrected value. | 07-30-2015 |
Patent application number | Description | Published |
20080249434 | Device and Method for Transporting and Handling Tissue - A device and method and provided for tissue handling, while maintaining the in-vivo tissue orientation. The device includes a structure, configured for receiving and holding a tissue specimen, wherein the tissue specimen includes tissue positional references; and device positional references, associated with the structure, for fixing the orientation of the tissue specimen, when held by the device, so as to reflect the tissue specimen positional references. | 10-09-2008 |
20090253978 | Graphical User Interfaces (GUI), Methods And Apparatus For Data Presentation - A graphical user interface (GUI) including: (a) a group definition module adapted to accept a user input defining groups; (b) a data receiver operable to receive a plurality of individual measurement input datum indicative of status of a substrate; (c) a grouping module configured to assign each of said individual measurement input datum to one of said groups to produce grouped data; and (d) an output module adapted to output the grouped data. | 10-08-2009 |
20100185138 | FLOW REGULATING IMPLANT, METHOD OF MANUFACTURE, AND DELIVERY DEVICE - An implant includes a tube for permitting fluid flow. A flow controlling rod may be inserted within the tube passage. One or more holes around the circumference of the tube may be selectively permanently or temporarily occluded to give desired flow characteristics. A delivery device for implanting the implant may include a central bore in which a retractable wire is located. The retractable wire penetrates a tube passage of the implant. After the implant is in position in the eye, the retention wire is retracted out of the implant. In a method for manufacturing an implant, two tubes of different diameters are utilized. The smaller tube fits inside the longitudinal bore of the larger tube. When the tubes are cut, the smaller tube forms the tube of the implant and the remaining portions of the larger tube form the retention projection and/or disk of the implant. | 07-22-2010 |
Patent application number | Description | Published |
20110171206 | ANTIBODY COMBINATIONS AND USE OF SAME FOR TREATING CANCER - A method of identifying a combination of antibodies with a combined improved anti-tumor activity is provided. The method comprising: (a) identifying binding epitopes of anti ErbB-2 antibodies; and (b) selecting a combination of at least two antibodies of the anti ErbB-2 antibodies exhibiting binding to different epitopes on the ErbB-2, at least one of the different epitopes being localized to a dimerization site of the ErbB-2, the combination of antibodies being with the combined improved anti-tumor activity. Also provided are novel antibody combinations uncovered according to the present teachings. | 07-14-2011 |
20110183437 | METHODS OF IDENTIFYING COMBINATIONS OF ANTIBODIES WITH AN IMPROVED ANTI-TUMOR ACTIVITY AND COMPOSITIONS AND METHODS USING THE ANTIBODIES - A method of identifying a combination of antibodies with a combined improved anti tumor activity is provided. The method comprising identifying at least two anti RTK antibodies capable of inducing synergistic endocytosis of the RTK in a cell expressing the RTK, thereby identifying the combination of antibodies with the combined improved anti-tumor activity. | 07-28-2011 |
20110236975 | GROWTH FACTOR WHICH ACTS THROUGH ERB B-4 RTK - The present invention provides for isolated polypeptides capable of binding ErbB-4. | 09-29-2011 |
20130034565 | MOLECULES AND METHODS OF USING SAME FOR TREATING ErbB/ErbB LIGANDS ASSOCIATED DISEASES - A method of selecting a target for treatment of a hyperproliferative disease in a subject in need thereof is disclosed. The method comprising analyzing an amount and/or activity of at least one ErbB ligand in a biological sample from the subject, wherein an ErbB ligand which shows an up-regulated amount and/or activity compared to a non-hyperproliferative cell or tissue above a predetermined level is selected as a target for treatment of the hyperproliferative disease. Methods of treating hyperproliferative diseases, monoclonal antibodies and pharmaceutical compositions are also disclosed. | 02-07-2013 |
20140086917 | COMBINATIONS OF ANTI ErbB ANTIBODIES FOR THE TREATMENT OF CANCER - An article-of-manufacture is provided. The article-of-manufacture comprises a packaging material identified for treating cancer, packaging:
| 03-27-2014 |
20140356350 | COMBINATION THERAPY TO PREVENT DCIS FORMATION AND PROGRESSION TO BREAST CANCER - A method of treating a ductal carcinoma in situ (DCIS) lesion in a subject in need thereof is disclosed. The method comprises administering to the subject a therapeutically effective amount of a first agent capable of down-regulating activity and/or expression of at least one component participating in a NOTCH pathway, and a second agent capable of down-regulating an activity and/or expression of HER2, thereby treating the DCIS lesion. | 12-04-2014 |
20150056216 | ANTIBODY COMBINATIONS AND USE OF SAME FOR TREATING CANCER - A method of identifying a combination of antibodies with a combined improved anti-tumor activity is provided. The method comprising: (a) identifying binding epitopes of anti ErbB-2 antibodies; and (b) selecting a combination of at least two antibodies of the anti ErbB-2 antibodies exhibiting binding to different epitopes on the ErbB-2, at least one of the different epitopes being localized to a dimerization site of the ErbB-2, the combination of antibodies being with the combined improved anti-tumor activity. Also provided are novel antibody combinations uncovered according to the present teachings. | 02-26-2015 |
20150266970 | COMBINATIONS OF EPIDERMAL GROWTH FACTOR RECEPTOR TARGETING ANTIBODIES FOR TREATING CANCER - A method of treating triple negative breast cancer in a subject comprising administering to the subject a therapeutically effective amount of a combination of at least two anti epidermal growth factor receptor (EGF-R) antibodies exhibiting binding to different epitopes on the EGF-R, thereby treating triple negative breast cancer. | 09-24-2015 |